AI assistant
Sending…
SELECT MEDICAL HOLDINGS CORP — Director's Dealing 2021
Mar 5, 2021
31892_dirs_2021-03-04_05db13d0-3245-4278-bf64-aa5c02baae69.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SELECT MEDICAL HOLDINGS CORP (SEM)
CIK: 0001320414
Period of Report: 2021-03-03
Reporting Person: ORTENZIO ROBERT A (Director, Exec. Chairman and Co-Founder)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-03 | Common Stock | S | 15898 | $34.00 | Disposed | 5140982 | Direct |
| 2021-03-03 | Common Stock | S | 10598 | $34.00 | Disposed | 1638402 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1445195 | Indirect |
| Common Stock | 3804805 | Indirect |
| Common Stock | 497156 | Indirect |
| Common Stock | 800000 | Indirect |
| Common Stock | 56669 | Indirect |
| Common Stock | 54553 | Indirect |
| Common Stock | 54553 | Indirect |
| Common Stock | 54552 | Indirect |
Footnotes
F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Robert A. Ortenzio on March 13, 2020.
F2: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Robert A. Ortenzio Descendants Trust on March 13, 2020.
F3: The reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
More from SELECT MEDICAL HOLDINGS CORP
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 4
Proxy Solicitation & Information Statement
2026
Mar 4
Regulatory Filings
2026
Mar 3
Annual Report
2026
Feb 19
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Jan 6
Regulatory Filings
2025
Dec 19